内大麻素系统
神经科学
生物
TRPV1型
大麻素受体
疾病
受体
大麻素
亨廷顿病
肌萎缩侧索硬化
瞬时受体电位通道
医学
内科学
生物化学
兴奋剂
作者
Alexandru Vasincu,Răzvan-Nicolae Rusu,Daniela Carmen Ababei,Mădălina Larion,Walther Bild,Gabriela Dumitriţa Stanciu,Carmen Solcan,Veronica Bild
出处
期刊:Biology
[Multidisciplinary Digital Publishing Institute]
日期:2022-03-14
卷期号:11 (3): 440-440
被引量:54
标识
DOI:10.3390/biology11030440
摘要
Neurodegenerative diseases are an increasing cause of global morbidity and mortality. They occur in the central nervous system (CNS) and lead to functional and mental impairment due to loss of neurons. Recent evidence highlights the link between neurodegenerative and inflammatory diseases of the CNS. These are typically associated with several neurological disorders. These diseases have fundamental differences regarding their underlying physiology and clinical manifestations, although there are aspects that overlap. The endocannabinoid system (ECS) is comprised of receptors (type-1 (CB1R) and type-2 (CB2R) cannabinoid-receptors, as well as transient receptor potential vanilloid 1 (TRPV1)), endogenous ligands and enzymes that synthesize and degrade endocannabinoids (ECBs). Recent studies revealed the involvement of the ECS in different pathological aspects of these neurodegenerative disorders. The present review will explore the roles of cannabinoid receptors (CBRs) and pharmacological agents that modulate CBRs or ECS activity with reference to Alzheimer's Disease (AD), Parkinson's Disease (PD), Huntington's Disease (HD) and multiple sclerosis (MS).
科研通智能强力驱动
Strongly Powered by AbleSci AI